Global Fund approves $2.4bn in new grants, warns of "tremendous demand"
This article was originally published in Clinica
The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced the approval of funding grants worth US$2.4bn over two years. It is the second-largest funding tranche in the history of the Global Fund, and brings its total commitment to programmes across 144 countries to $18.4bn since its creation in 2002. Details of the latest prevention and care projects to benefit from the programme were not available.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.